The antibody exerts an anti-tumor effect by tightly inhibiting the homodimerization of cytoplasmic tyrosine kinase regions of HER2 and heterodimerization of HER2/HER3, which are important steps for HER2-mediated oncogenic signaling cascades. The gene discussed is ERBB2; the disease is neoplasm.